First‐in‐Human Evaluation of Safety, Pharmacokinetics and Muscle Glycogen Lowering of a Novel Glycogen Synthase 1 Inhibitor for the Treatment of Pompe Disease
2024 · Clinical Pharmacology & Therapeutics · 5 citations
https://doi.org/10.1002/cpt.3470
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
56
Citations
3
h-index
2
i10-index
Daniela Linzner is an academic researcher from Maze (United States). The author has contributed to research in topics: Lysosomal Storage Disorders Research & Glycogen Storage Diseases and Myoclonus & Immune Response and Inflammation. The author has an h-index of 3, co-authored 4 publications.
Click to start Chat